Home | Business News | CBJ Newsmakers | ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors CBJ Newsmakers RecommendedAqualitas Inc. Finalizes Supply Agreement and Launches Products with Medical Cannabis by Shoppers Inc.Woodbridge Ventures and Jack Nathan Medical Announce Closing of Subscription Receipt OfferingRelevium Licenses Patented Science-Based Natural Formulation That Addresses Major Points of Viral Invasion, Replication and Toxicities
